Inhibition of the transcription factor nuclear factor-κB by adenoviral- mediated expression of IκBαM results in tumor cell death

Surgery

Volumn 126, Issue 2, 1999, Pages 399-405

  Feig, Barry W ^a   Xiaolin, Lu ^a   Hunt, Kelly K ^a   Shan, Qin ^a   Dihua, Yu ^a   Pollock, Raphael ^a   Chiao, Paul ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR CELL;

EID: 0032854673     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70184-4     Document Type: Article

References (20)

1. 1. Grilli M, Chiu JJS, Lenardo MJ. NF-kB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993;143:1-62.
2. 2. Wang CY, Mayo MW, Baldwin AS. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 1996;274:784-7.
3. 3. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA. IkB interacts with the nuclear localization sequences of the subunits of NF-kB: a mechanism for cytoplasmic retention. Genes Dev 1992;6:1899-913.
4. 4. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, et al. Coupling of a signal response domain in IkB to multiple pathways for NF-kB activation. Mol Cell Biol 1995;15:2809-18.
5. 5. Traencker EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human IkB on serines 32 and 36 controls IkB proteolysis and NF-kB activation in response to diverse stimuli. EMBO J 1995;14:2876-83.
6. 6. Brown K, Gerstberger FS, Carlson L, Franzoso G, Siebenlist U. Control of IkBα proteolysis by site-specific, signal-induced phosphorylation. Science 1995;267:1485-91.
7. 7. Chen ZJ, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, et al. Signal-induced site-specific phosphorylation targets IkB to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-97.
8. 8. Lienard D, Ewalenko P, Delmotte, JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52-60.
9. 9. Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA, Benjamin RS, et al. Preoperative chemotherapy for soft-tissue sarcomas of the exremities. Ann Surg 1990;211:476-81.
10. 10. Casper ES, Gaynor JJ, Harrison LB, Panieck DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73:1644-51.
11. 11. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor I signal transduction pathways. Cell 1996;84:299-308.
12. 12. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67
13. 13. Nolan GP, Baltimore D. The inhibitory ankyrin and activator Rel proteins. Curr Opin Gene Dev 1992;2:211-20.
14. 14. Beg AA, Baldwin AS. The IkB proteins: multifunctional regulators of Rel/NF-kB transcription factors. Genes Dev 1993;7:2064-70.
15. 15. Liou HC, Baltimore D. Regulation of the NF-kB/rel transcription factor and IkB inhibitory system. Curr Opin Cell Biol 1993;5:477-87.
16. 16. Beg AA, Sha WC, Ghosh S, Bronson RT, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kB. Nature 1995;376:167-70.
17. 17. Wang CY, Mayo MW, Baldwin AS. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 1996;274:784-7.
18. 18. Eggermont AAM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Lienard D, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas: the cumulative multicenter European experience. Ann Surg 1996;224:756-65.
19. 19. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
20. 20. Zhang W-W, Alemany R, Wang J, Koch PE, Ordonez NG, Roth JA. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum Gene Ther 1995;6:155-64.